Health care companies by P/S ratio
Market value divided by the latest fiscal year's revenue: what the market pays for each dollar of sales.
Centene has the lowest figure of the 154 health care companies ranked by P/S ratio, at 0.2, followed by Cencora (0.2) and Molina Healthcare (0.2). Figures as of 19 Nov 2026, 14:43 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 154
- Lowest
- Centene0.2
- Median
- 4.3
- Combined market value
- AED 33.12T
- Countries
- 14
- Not ranked
- 16no P/S ratio on file
Market values as of .
All countries▾
Health Care▾
All categories▾
| # | Company | P/S ↑ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 101 | Caris Life SciencesCAI · Health Care | 7.1 | AED 21.2B | AED 73.82 | 3.08% up | 19% down | ||
| 102 | Medpace HoldingsMEDP · Health Care | 7.2 | AED 66.7B | AED 2,382.86 | 0.30% up | 10% up | ||
| 103 | Agilent TechnologiesA · Health Care | 7.2 | AED 184.2B | AED 653.17 | 0.33% up | 22% up | ||
| 104 | Arrowhead PharmaceuticalsARWR · Health Care | 7.3 | AED 22.3B | AED 158.01 | 0.20% down | 13% up | ||
| 105 | IlluminaILMN · Health Care | 7.4 | AED 118.7B | AED 785.37 | 1.83% up | 76% up | ||
| 106 | Halozyme TherapeuticsHALO · Health Care | 7.6 | AED 38.7B | AED 339.75 | 3.43% down | 39% up | ||
| 107 | United TherapeuticsUTHR · Health Care | 7.7 | AED 89.5B | AED 2,101.83 | 0.87% down | 22% up | ||
| 108 | AbbVieABBV · Health Care | 8.2 | AED 1.83T | AED 1,036.83 | 1.27% down | 25% up | ||
| 109 | GenmabGMAB · Health Care | 8.6 | AED 116.9B | AED 189.58 | 1.28% up | 70% up | ||
| 110 | Mettler-Toledo InternationalMTD · Health Care | 8.6 | AED 126.9B | AED 6,378.99 | 0.04% down | 24% up | ||
| 111 | BeOne MedicinesONC · Health Care | 8.6 | AED 169.2B | AED 1,481.12 | 0.08% down | 16% up | ||
| 112 | PenumbraPEN · Health Care | 9.0 | AED 46.4B | AED 1,177.51 | 0.04% up | 15% up | ||
| 113 | West Pharmaceutical ServicesWST · Health Care | 9.1 | AED 102.4B | AED 1,470.20 | 0.92% down | 57% up | ||
| 114 | Bio-TechneTECH · Health Care | 9.4 | AED 41.9B | AED 267.04 | 0.05% down | 24% up | ||
| 115 | Madrigal PharmaceuticalsMDGL · Health Care | 9.7 | AED 34.3B | AED 1,474.59 | 0.86% up | 27% down | ||
| 116 | Corcept TherapeuticsCORT · Health Care | 9.7 | AED 27.2B | AED 248.87 | 0.04% down | 10% down | ||
| 117 | Travere TherapeuticsTVTX · Health Care | 9.9 | AED 17.8B | AED 185.34 | 0.45% up | 45% up | ||
| 118 | Edwards LifesciencesEW · Health Care | 10.0 | AED 221.8B | AED 385.77 | 0.15% down | 25% up | ||
| 119 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | 11.0 | AED 27.4B | AED 348.73 | 0.10% down | 129% up | ||
| 120 | Axsome TherapeuticsAXSM · Health Care | 11.1 | AED 26B | AED 495.21 | 0.63% up | 6% down | ||
| 121 | Vertex PharmaceuticalsVRTX · Health Care | 11.3 | AED 496.9B | AED 1,959.77 | 0.53% down | 27% up | ||
| 122 | Mirum PharmaceuticalsMIRM · Health Care | 11.6 | AED 22.2B | AED 340.12 | 0.13% up | 34% up | ||
| 123 | 10x GenomicsTXG · Health Care | 12.2 | AED 28.8B | AED 219.07 | 4.52% up | 247% up | ||
| 124 | IDEXX LaboratoriesIDXX · Health Care | 12.7 | AED 200.6B | AED 2,545.70 | 0.76% down | 1% up | ||
| 125 | argenxARGX · Health Care | 14.2 | AED 216.5B | AED 3,442.47 | 0.42% down | 2% up | ||
| 126 | BillionToOneBLLN · Health Care | 14.5 | AED 16.2B | AED 339.94 | 1.11% up | 4% down | ||
| 127 | Intuitive SurgicalISRG · Health Care | 14.5 | AED 537B | AED 1,549.14 | 0.20% up | 24% down | ||
| 128 | RepligenRGEN · Health Care | 15.3 | AED 41.4B | AED 647.46 | 2.10% up | 12% up | ||
| 129 | TG TherapeuticsTGTX · Health Care | 16.2 | AED 36.7B | AED 242.91 | 0.03% up | 117% up | ||
| 130 | Royalty PharmaRPRX · Health Care | 16.6 | AED 144.7B | AED 251.61 | 0.23% down | 79% up | ||
| 131 | Adaptive BiotechnologiesADPT · Health Care | 17.1 | AED 17.4B | AED 107.23 | 2.59% up | 74% up | ||
| 132 | NateraNTRA · Health Care | 18.6 | AED 157.6B | AED 1,087.09 | 2.25% up | 28% up | ||
| 133 | Eli LillyLLY · Health Care | 18.7 | AED 4.47T | AED 5,019.27 | 1.13% down | 33% up | ||
| 134 | Guardant HealthGH · Health Care | 21.1 | AED 76.2B | AED 563.01 | 5.62% up | 45% up | ||
| 135 | Twist BioscienceTWST · Health Care | 21.5 | AED 29.8B | AED 437.04 | 2.28% up | 346% up | ||
| 136 | Ligand PharmaceuticalsLGND · Health Care | 22.2 | AED 21.8B | AED 1,090.62 | 0.59% down | 50% up | ||
| 137 | Ascendis PharmaASND · Health Care | 22.2 | AED 65B | AED 991.60 | 0.12% down | 29% up | ||
| 138 | HeartflowHTFL · Health Care | 23.5 | AED 15.2B | AED 172.69 | 2.46% up | 66% up | ||
| 139 | Krystal BiotechKRYS · Health Care | 24.0 | AED 34.3B | AED 1,158.17 | 0.00% up | 54% up | ||
| 140 | GlaukosGKOS · Health Care | 27.4 | AED 51.1B | AED 863.06 | 0.82% up | 145% up | ||
| 141 | WatersWAT · Health Care | 28.9 | AED 335.4B | AED 1,706.77 | 0.29% down | 23% up | ||
| 142 | BridgeBio PharmaBBIO · Health Care | 30.8 | AED 56.7B | AED 291.27 | 1.67% up | 21% up | ||
| 143 | GRAILGRAL · Health Care | 32.8 | AED 17.7B | AED 394.49 | 5.21% up | 19% up | ||
| 144 | ModernaMRNA · Health Care | 40.8 | AED 291.4B | AED 720.23 | 0.35% down | 780% up | ||
| 145 | Rhythm PharmaceuticalsRYTM · Health Care | 43.2 | AED 30.1B | AED 434.60 | 0.59% down | 18% up | ||
| 146 | InsmedINSM · Health Care | 43.8 | AED 97.5B | AED 444.48 | 1.02% up | 40% down | ||
| 147 | ImmunityBioIBRX · Health Care | 62.6 | AED 26.1B | AED 24.50 | 0.45% down | 232% up | ||
| 148 | CytokineticsCYTK · Health Care | 81.8 | AED 26.5B | AED 189.87 | 0.74% up | 19% down | ||
| 149 | Protagonist TherapeuticsPTGX · Health Care | 180 | AED 30.5B | AED 467.21 | 0.04% up | 51% up | ||
| 150 | Kymera TherapeuticsKYMR · Health Care | 263 | AED 37.8B | AED 443.17 | 0.38% down | 87% up | ||
| 151 | CRISPR TherapeuticsCRSP · Health Care | 1117 | AED 14.4B | AED 148.41 | 0.55% up | 18% down | ||
| 152 | CG OncologyCGON · Health Care | 1793 | AED 26.6B | AED 297.85 | 1.37% up | 97% up | ||
| 153 | Dianthus TherapeuticsDNTH · Health Care | 2391 | AED 17.9B | AED 317.42 | 2.92% up | 108% up | ||
| 154 | Roivant SciencesROIV · Health Care | 3426 | AED 103.9B | AED 143.45 | 0.85% up | 91% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. P/S divides today's market value by the latest fiscal year's revenue from the annual report. Sums are converted from US dollars at today's exchange rate (1 USD = 3.6726 AED). 16 companies have no P/S ratio on file and are not ranked here.
Questions and answers
Which health care companies have the lowest P/S ratio?
Centene (0.2), Cencora (0.2) and Molina Healthcare (0.2) have the lowest P/S ratio of the 154 health care companies ranked here as of 19 Nov 2026, 14:43 UTC.
How many health care companies are in this ranking?
154 are ranked by P/S ratio. 16 more have no P/S ratio on file and are left out rather than ranked at zero.
What are these health care companies worth together?
The 154 health care companies ranked by P/S ratio have a combined market value of AED 33.12T as of 19 Nov 2026, 14:43 UTC.
What does ranking by P/S ratio measure?
Market value divided by the latest fiscal year's revenue: what the market pays for each dollar of sales.
Learn how this ranking works
All markets guides →- P/E ratio explained: what a high or low figure means
The price-to-earnings (P/E) ratio is a share's price divided by its earnings per share. A stock at $100 earning $5 a share has a P/E of 20: buyers pay $20 for each dollar of yearly profit. A high P/E usually means the market expects profit to grow; a low one can mean doubt, not a bargain.
- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Health care companies by P/S ratio”, data as of 19 November 2026. https://funkfolio.com/companies/sector/health-care?by=ps-ratio
Underlying data: Yahoo Finance; SEC EDGAR.